I was right about one thing - directors are buying around the 30c mark. Let's hope I'm right about another thing which is that XTE will trade significantly higher this time next year.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025